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Abstract. 
 
The mammalian protein TAP/p115 and its 
yeast homologue Uso1p have an essential role in mem-
brane traffic (Nakajima et al., 1991; Waters et al., 1992; 
Sztul et al., 1993; Rabouille et al., 1995). To inquire into 
the site and mechanism of TAP/p115 action, we aimed 
to localize it and to identify domains required for its 
function. We show that in interphase cells, TAP/p115 
localizes predominantly to the Golgi and to peripheral 
structures that represent vesicular tubular clusters 
(VTCs) involved in ER to Golgi transport. Using BFA/
nocodazole treatments we confirm that TAP/p115 is 
present on ER to Golgi transport intermediates. TAP/
p115 redistributes to peripheral structures containing 
ERGIC-53 during a 15
 
8
 
C treatment, suggesting that it is 
a cycling protein. Within the Golgi, TAP/p115 is associ-
 
ated with pleiomorphic structures on the 
 
cis
 
 side of the 
 
cis
 
-Golgi cisterna and the 
 
cis
 
-most cisterna, but is not 
detected in more distal compartments of the Golgi.
TAP/p115 binds the 
 
cis
 
-Golgi protein GM130, and 
the COOH-terminal acidic domain of TAP/p115 is re-
quired for this interaction. TAP/p115 interaction with 
GM130 occurs only in the Golgi and is not required for 
TAP/p115 association with peripheral VTCs. To exam-
ine whether interaction with GM130 is required to re-
cruit TAP/p115 to the Golgi, TAP/p115 mutants lack-
ing the acidic domain were expressed and localized in 
transfected cells. Mutants lacking the GM130-binding 
domain showed normal Golgi localization, indicating 
that TAP/p115 is recruited to the Golgi independently 
of its ability to bind GM130. Such mutants were also 
able to associate with peripheral VTCs. Interestingly, 
TAP/p115 mutants containing the GM130-binding do-
main but lacking portions of the NH
 
2
 
-terminal region 
were restricted from the Golgi and localized to the ER. 
The COOH-terminal domain required for GM130 
binding and the NH
 
2
 
-terminal region required for 
Golgi localization appear functionally relevant since 
expression of TAP/p115 mutants lacking either of these 
domains leads to loss of normal Golgi morphology.
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M
 
ovement
 
 of membrane and cargo through the
secretory pathway proceeds via transport inter-
mediates that originate from one compartment
and fuse with the next compartment in the pathway.
Through a combination of yeast genetics, neurochemistry,
and cell-free transport assays, a number of proteins have
been identified that regulate the fusion process. Prominent
among these are the transmembrane proteins known as
SNAREs. According to the SNARE
 
1
 
 (
 
N
 
-ethylmaleimide–
sensitive factor attachment protein receptor) hypothesis,
fusion of a transport vesicle with its target membrane is
dependent on pairing of a compartment-specific vesicle
(v)-SNARE with its cognate target (t)-SNARE (Söllner et
al., 1993; Rothman, 1994). Consistent with the idea that
SNAREs provide specificity in fusion of transport vesicles
with their target, a growing number of v- and t-SNAREs
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1. 
 
Abbreviations used in this paper
 
: DOC, deoxycholate; ERGIC, ER to
Golgi intermediate compartment; IF, immunofluorescence; NSF, 
 
N
 
-ethyl-
maleimide–sensitive factor; PNS, postnuclear supernatant; SG, stacked
Golgi; SNAP, soluble NSF atttachment protein; SNARE, 
 
N
 
-ethylmale-
imide–sensitive factor attachment protein; t-SNARE, target SNARE;
v-SNARE, vesicle SNARE; VTC, vesicular tubular cluster. 
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have been identified and linked to specific stages of trans-
port (Pfeffer, 1996; Hay and Scheller, 1997).
Distinct families of proteins are known to regulate fu-
sion by modulating SNARE interactions. Proteins of the
sec1/sly1 family associate with t-SNAREs before SNARE
complex assembly and appear to regulate t-SNAREs in
both a positive and negative manner (Pevsner, 1996; Hala-
machi and Lev, 1996). The rab/ypt1 group of ras related
GTPases also regulate SNARE complex formation (Pfef-
fer, 1994; Novick and Zerial, 1997), and there is evidence
that they associate with and activate t-SNAREs (Lupa-
shin and Waters, 1997). Like SNAREs, the individual
members of the sec1/sly1 and rab/ypt1 families of proteins
act at specific transport stages.
Additional proteins have been shown to be required
during events leading up to membrane fusion. Bovine
p115 was initially purified as a soluble factor required in
an intra-Golgi transport assay (Waters et al., 1992) and
subsequently shown to be also essential in a cell-free assay
reconstituting regrowth of Golgi cisternae from postmi-
totic Golgi fragments (Rabouille et al., 1995, 1998). Within
that assay, binding of p115 to the 
 
cis
 
-Golgi matrix protein
GM130 is required for cisternal regrowth (Nakemura et
al., 1997). The rat protein TAP was found to be necessary
in an assay measuring fusion of transcytotic vesicles with
the plasma membrane (Sztul et al., 1993). Dissection of
this assay into docking and fusion steps showed that TAP
is required for vesicle docking to the target membrane be-
fore fusion (Barroso et al., 1995). Cloning of bovine p115
and rat TAP revealed them to be 90% identical (Barroso
et al., 1995; Sapperstein et al., 1995) with homology to
yeast Uso1p (Nakajima et al., 1991). Sequence similarity
between TAP/p115 and Uso1p is highest in three homol-
ogy regions (H1, H2, and H3). H1 and H2 are found in the
NH
 
2
 
-terminal approximately one-third
 
 
 
of TAP/p115. H3 is
at the COOH terminus and contains an acidic domain at
the extreme COOH terminus. Analysis of TAP/p115 and
Uso1p with the COILS program (Lupas et al., 1991) pre-
dicts extensive coiled-coil formation in the COOH-termi-
nal region, which likely form the rod-like tail (Barroso et
al., 1995; Sapperstein et al., 1995; Yamakawa et al., 1996).
In agreement, electron micrographs of purified TAP/p115
show a homodimer, similar in overall appearance to myo-
sin, with two globular heads and an extended rod-like tail
(Sapperstein et al., 1995). Uso1p has a similar ho-
modimeric structure, with a longer tail than TAP/p115
(Yamakawa et al., 1996). Uso1p has been shown to be in-
volved in ER to Golgi transport (Nakajima et al., 1991),
and more recently, for the formation of the ER to Golgi
SNARE complex (Sapperstein et al., 1996), at a step be-
fore ATP hydrolysis by NSF (Lupashin et al., 1996). In
agreement with the tethering function shown for TAP/
p115, Uso1p appears required for docking of ER-derived
vesicles with Golgi membranes (Barlowe, 1997). The elon-
gated structure of TAP/p115 and Uso1p seem suited to
their proposed function in the docking of transport vesi-
cles with target membrane (Barroso et al., 1995, Bajjalieh
and Scheller, 1995; Sapperstein et al., 1996; Barlowe, 1997;
Lowe et al., 1998; Orci et al., 1998).
To further investigate the role of TAP/p115 in mem-
brane transport, we sought to identify subcellular com-
partments in which it is present and identify regions within
TAP/p115 mediating its localization and its interactions
with other proteins. In this report, we show that TAP/p115
is associated with peripheral vesicular tubular clusters
(VTCs), with pleiomorphic structures adjoining the 
 
cis
 
-
side of the Golgi stack and the 
 
cis
 
-most Golgi cisterna, and
that it cycles between the Golgi and earlier compartments
of the secretory pathway. Within the Golgi, TAP/p115 in-
teracts with the 
 
cis
 
-Golgi protein GM130. This interaction
is not required for Golgi localization of TAP/p115 but is
functionally essential since expression of TAP/p115 mu-
tants lacking the GM130-binding domain lead to Golgi
structure disruption. In addition, the combination of re-
combinant protein binding and transfection assays identi-
fied another relevant region within TAP/p115: the NH
 
2
 
-
terminal H2 domain is required for TAP/p115 localization
to the Golgi and expression of NH
 
2
 
 terminally truncated
TAP/p115 results in a loss of compact Golgi morphology
in transfected cells.
 
Materials and Methods
 
Antibodies
 
Rabbit polyclonal antibodies against TAP/p115 were generated by immu-
nization with affinity-purified rat TAP/p115. The anti-TAP monoclonal
antibody 5D6 has been described previously (Barroso et al., 1995). Mouse
and rabbit polyclonal antibodies against GM130 were generated by immu-
nization with inclusion bodies from bacteria expressing full-length
GM130. Anti-giantin monoclonal G1/133 (Linstedt and Hauri, 1993) and
anti–ERGIC-53 monoclonal G1/93 (Schweizer et al., 1988) were provided
by H.-P. Hauri (University of Basel, Basel, Switzerland). Polyclonal anti-
bodies against mannosidase II were kindly provided by M. Farquhar (Uni-
versity of California, San Diego, CA). Monoclonal antibodies against
mannosidase II were purchased from Berkeley Antibody Co. (Berkeley,
CA). Monoclonal antibodies against the Golgi marker 58K (Golgi 58K
protein) were purchased from Sigma Biosciences (St. Louis, MO). Poly-
clonal antibodies against calnexin (SPA-860) were purchased from Stress-
Gen Biotechnologies (Victoria, BC, Canada). Goat anti–rabbit and anti–
mouse antibodies conjugated with FITC or rhodamine were purchased
from Jackson ImmunoResearch Laboratories (West Grove, PA).
 
Affinity Purification and Cross-linking of Antibodies
 
TAP/p115 was affinity purified from rat liver cytosol using the 5D6 mono-
clonal antibody as previously described (Barroso et al., 1995), run on 7.5%
acrylamide gels, and then transferred to nitrocellulose. Strips of nitrocel-
lulose containing TAP/p115 were incubated with immune serum in PBS,
5% dried milk, and 0.1% Tween 20 for 3 h at room temperature. Bound
antibodies were eluted with 0.1 M glycine, pH 3.0, then neutralized with a
0.1 vol of 1 M Tris, pH 7.4. Anti-TAP/p115 antibodies were cross-linked to
protein A–Sepharose 4 FF (Pharmacia Biotech, Piscataway, NJ) with di-
methyl pimelimidate (Pierce Chemical Co., Rockford, IL) according to
the manufacturer’s protocol.
 
Fractionation of Rat Liver
 
Rat liver fractions were prepared by modification of a procedure previ-
ously described (Taylor et al., 1997). 200–300-g Sprague-Dawley rats were
anesthetized with sodium pentobarbital. Livers were excised and chilled
and subsequent steps were performed on ice or at 4
 
8
 
C. Livers were
minced, washed three times in PBS, and then resuspended in 3 vol of
buffer containing 0.5 M sucrose, 0.1 M potassium phosphate, 5 mM
MgCl
 
2
 
, 1 mM DTT, pH 7.0, 0.5 M SPMD. The SPMD buffer contained the
protease inhibitors antipain (2 
 
m
 
g/ml), aprotinin (5 
 
m
 
g/ml), leupeptin (5
 
m
 
g/ml), and pepstatin (1 
 
m
 
g/ml). The sample was homogenized by 15
strokes in a 40-ml Dounce tissue grinder (Wheaton, Millville, NJ) and
spun at 1,000 
 
g
 
 for 10 min. The postnuclear supernatant (PNS) was ap-
plied to a sucrose step gradient consisting of 1.3 M SPMD, 0.86 M SPMD,
the PNS in 0.5 M SPMD, and 0.25 M SPMD. The gradient was centrifuged
for 2 h at 25,000 rpm in a Beckman SW28 rotor (Beckman Instrs., Fuller- 
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ton, CA). Fractions were removed from the top of the tube using a Pas-
teur pipette. The cytosolic fraction was collected from the 0.5 M SPMD
layer. The stacked Golgi (SG) fraction was collected at the 0.5 M–0.86 M
SPMD interface. The 0.86 M and 1.3 M SPMD layers were collected and
pooled to make up the ER fraction.
 
Immunoprecipitation
 
Fractions were solubilized in a buffer containing 20 mM Hepes, 100 mM
KCl, pH 7.4, 1 mM MgCl
 
2
 
, 0.1 mM EDTA, 1 mM DTT (HKMED) and
1% Triton X-100 or a combination of 1% Triton X-100, 0.5% deoxycho-
late, and 0.1% SDS. After incubation at 4
 
8
 
C for 30 min, samples were cen-
trifuged at 16,000 
 
g
 
 for 15 min. Supernatants were incubated at 4
 
8
 
C with
anti-TAP/p115 antibodies for 2 h and protein A–Sepharose 4 FF for 1 h,
and then washed four times with HKMED buffer containing the detergent
used for solubilization. Precipitates were analyzed by SDS-PAGE fol-
lowed by silver staining (Ansorge et al., 1985).
 
Purification of p135 for Peptide Sequencing
 
The SG fractions obtained from 10 rat livers were pooled and solubilized
in HKMED 1% Triton X-100 for 30 min. p135 was purified from the SG
fraction by coimmunoprecipitation with TAP/p115 using affinity-purified
anti-TAP/p115 antibodies cross-linked to protein A–Sepharose 4 FF.
Bound protein was eluted from beads with 0.1 M cyclohexylaminopro-
panesulfonic acid buffer, pH 10.5. The eluted protein was precipitated by
addition of four parts 50:50 methanol/acetone solution followed by chill-
ing overnight at 
 
2
 
20
 
8
 
C and centrifugation at 16,000 
 
g
 
. The precipitated
protein was analyzed on 7.5% SDS-PAGE and stained with Coomassie
brilliant blue R-250. Approximately 8 
 
m
 
g of p135 were obtained. A gel
slice containing p135 was excised and washed three times in 50:50 water/
acetonitrile. Preparation of p135 peptides from the gel slice by trypsin di-
gestion and HPLC microbore separation, and peptide sequencing by Ed-
man degradation was performed by Harvard University Microchemistry.
 
TAP/p115 and GM130 Constructs
 
NH
 
2
 
 terminally truncated GM130 (GM130-N75) was cloned by PCR from
a rat brain cDNA library. A Bluescript plasmid encoding full-length
GM130 was a gift of N. Nakamura and G. Warren. TAP/p115 mutants
were constructed using restriction sites within the sequence, or restriction
sites were introduced by PCR. Standard molecular techniques were used
for growth of bacteria, plasmid purification, plasmid digestion, and trans-
formation of bacteria (Sambrook et al., 1989).
 
TAP/p115 In Vitro Binding Experiments
 
To test binding of full-length and truncated forms of TAP/p115 and
GM130, proteins encoded in pET21b or pET21c vectors were expressed
in 
 
Escherichia coli
 
 BL21. Cells were lysed by sonication in 100 mM KCl,
20 mM Tris, pH 7.4, 1 mM DTT (100 KTD) and centrifuged at 100,000 
 
g
 
for 1 h, and the resulting supernatants were used for binding experiments.
Bacterial supernatants containing TAP FL, TAP-C934, TAP-C708, TAP-
N372, or TAP/p115 from rat liver cytosol were incubated with supernatant
containing GM130-FL or GM130 N-75 in 100 KTD, 1% Triton X-100.
Samples were immunoprecipitated with affinity purified polyclonal anti-
TAP/p115 antibodies and analyzed by SDS-PAGE. The percent of
GM130 in the binding reaction that coprecipitated with TAP/p115 was de-
termined by scanning gels with a Bio-Rad GS-700 imaging densitometer
(Bio-Rad Laboratories, Hercules, CA).
 
Immunofluorescence Microscopy
 
Cells grown on glass coverslips were washed three times in PBS and fixed
in 3% paraformaldehyde in PBS for 10 min at room temperature.
Paraformaldehyde was quenched with 10 mM ammonium chloride and
cells were permeabilized with PBS, 0.1% Triton X-100 for 7 min at room
temperature. The coverslips were washed three times for 5 min each with
PBS, 0.2% Tween 20, then blocked in PBS, 0.4% fish skin gelatin, 0.2%
Tween 20 for 5 min, followed by blocking in PBS, 2.5% goat serum, 0.2%
Tween for 5 min. Cells were incubated with primary antibody diluted in
PBS, 0.4% fish skin gelatin, 0.2% Tween 20 for 45 min at 37
 
8
 
C. Coverslips
were washed five times for 5 min each with PBS, 0.2% Tween 20. Second-
ary antibodies coupled to FITC or rhodamine were diluted in 2.5% goat
serum and incubated on coverslips for 30 min at 37
 
8
 
C. Coverslips were
washed as above and mounted on slides in 9:1 glycerol/PBS with 0.1%
 
q
 
-phenylenediamine. Slides were examined on a Leitz Orthoplan micro-
scope (Wetzlar, Germany) equipped for epifluorescence. Photographs
were taken on Kodak Gold film (Eastman Kodak Co., Rochester, NY) at
1,000 ASA with an adjoining Leitz Orthomal camera system.
 
Transfection of COS-7 Cells
 
COS-7 cells growing on coverslips were transiently transfected using a cal-
cium phosphate transfection system (GIBCO BRL, Gaithersburg, MD).
5 
 
m
 
g of DNA expressing the appropriate TAP/p115 construct was used
per 10-mm dish of cells. 24 h after transfection, cells were lysed with 0.5 ml
of 50 mM Tris-HC1, pH 7.5, 150 mM NaC1, 1% NP-40, 0.5% DOC, 0.1%
SDS (RIPA) buffer, the lysate was centrifuged at 1,000 
 
g
 
 for 10 min, and
the resulting PNS was recovered. PNS was processed for SDS-PAGE, the
gel transferred to NC, and the filter was immunoblotted with anti-rat
TAP/p115 antibodies.
 
Results
 
TAP/p115 Cycles between the Golgi and Earlier 
Secretory Compartments
 
TAP/p115 has been localized to the Golgi by immunofluo-
rescence microscopy (Waters et al., 1992; Nakamura et al.,
1997), and more specifically to the 
 
cis
 
-side of the Golgi by
confocal microscopy (Shima et al., 1997). In agreement
with these results, we found that TAP/p115 colocalizes
with the Golgi marker giantin (Linstedt and Hauri, 1993)
in a characteristic juxtanuclear pattern in normat rat kid-
ney cells (Fig. 1, 
 
A
 
–
 
C
 
). In addition, TAP/p115 was seen in
peripheral punctate structures that did not contain giantin
(Fig. 1 
 
C
 
, 
 
arrowheads
 
). Distribution to both the Golgi and
peripheral structures is suggestive of the pattern seen with
proteins occupying the ER to Golgi intermediate compart-
ment (ERGIC) and cycling between the ER and the Golgi
(for review see Hauri and Schweizer, 1992; Pelham, 1997;
Bannykh and Balch, 1997). The ERGIC is made up of
pleiomorphic transport intermediates described as VTCs
(Bannykh et al., 1998; Balch et al., 1994). VTCs form
throughout the cell, translocate in a microtubule depen-
dent manner to the 
 
cis
 
-region of the Golgi, where they ap-
pear to merge with the Golgi (Presley et al., 1997; Scales
et al., 1997).
To determine if TAP/p115 localizes to VTCs, the distri-
bution of TAP/p115 and the VTC marker ERGIC-53
(Schweizer et al., 1988, 1991) were compared in COS-7
cells. As shown in Fig. 1 
 
D
 
, TAP/p115 was found in the
Golgi and in peripheral punctate structures. ERGIC-53
(Fig. 1 
 
E
 
) was detected in the Golgi and in peripheral
VTCs, in agreement with its localization in COS-1 cells
(Itin et al., 1995). TAP/p115 and ERGIC-53 colocalized
in the Golgi region and in the peripheral punctate struc-
tures (Fig. 1 
 
F
 
), suggesting that TAP/p115 is present in
VTCs and is likely to cycle between the Golgi and ear-
lier compartments of the secretory pathway.
ERGIC-53 is a cycling protein and to confirm that TAP/
p115 also cycles, its distribution was compared with that of
ERGIC-53 in cells incubated at reduced temperature. In-
cubation of cells at 15
 
8
 
C inhibits the anterograde transport
of VTCs from the periphery to the Golgi region, whereas
retrograde transport appears less affected. The net effect
on the localization of cycling proteins is a redistribution
from the Golgi to enlarged peripheral VTCs (Lippincott-
Schwartz et al., 1990; Schweizer et al., 1990; Saraste and
Svensson, 1991). To determine if TAP/p115 exhibits such 
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redistribution, cells were incubated at 15
 
8
 
C for 2 h, and
TAP/p115 and ERGIC-53 were then localized. TAP/p115
(Fig. 1 
 
G
 
) and ERGIC-53 (Fig. 1 
 
H
 
) were present in en-
larged peripheral elements scattered throughout the cell
and colocalized in all structures (Fig. 1 
 
I
 
, 
 
arrowheads
 
).
These results suggest that TAP/p115 cycles between pe-
ripheral VTCs and the Golgi. It is possible that TAP/p115,
like ERGIC-53, cycles through the ER, but this remains to
be determined.
VTCs have been shown to mediate transport of cargo
from the ER to the Golgi (Presley et al., 1997). To show
directly that structures containing TAP/p115 are transport
intermediates, their role in mannosidase II transport from
the ER to the Golgi was analyzed. NRK cells were first
treated with BFA to relocate mannosidase II from the 
 
me-
dial
 
-Golgi to the ER. After a 30-min BFA treatment, man-
nosidase II was detected in a characteristic ER pattern
(Fig. 2 
 
B
 
), whereas TAP/p115 was found in punctate struc-
Figure 1. TAP/p115 is a cy-
cling protein. NRK or COS-7
cells were incubated at 378 or
at 158C for 2 h, fixed, and
then processed for IF. In
NRK cells, TAP/p115 (A)
colocalizes with the Golgi
marker giantin (B) in a peri-
nuclear region. TAP/p115 is
also present in peripheral
punctate structures that do
not contain giantin (arrow-
heads in C). In COS-7 cells
incubated at 378C, TAP/
p115 (D) and ERGIC-53 (E)
colocalize in a juxtanuclear
region and in peripheral
punctate structures (F). In
COS-7 cells incubated at
158C, TAP/p115 (G) and
ERGIC-53 (H) colocalize
in dispersed punctate struc-
tures (arrowheads in I). Bar,
10 mm. 
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tures scattered throughout the cell (Fig. 2
 
 A
 
). Cells were
then treated with nocodazole for 90 min to depolymerize
microtubules. Addition of nocodazole did not cause a
change in mannosidase II or TAP/p115 patterns (data not
shown). BFA was then washed out during a 30-min incu-
bation at 37
 
8
 
C in the presence of nocodazole to prevent
movement of VTCs towards the microtubule organizing
center (MTOC). As shown in Fig. 2, 
 
C
 
 and 
 
D
 
, mannosi-
dase II moved from the ER into the TAP/p115-containing
structures, in agreement with previous results showing that
traffic from the ER to VTCs is not microtubule dependent
(Cole et al., 1996). Subsequent wash-out of nocodazole
during a 45-min incubation at 37
 
8
 
C leads to migration of
structures containing TAP/p115 and mannosidase II to-
wards the MTOC and their coalescence to form a normal
Golgi structure (Fig. 2, 
 
E
 
 and 
 
F
 
). These results suggest that
functional transport intermediates contain TAP/p115.
Within the Golgi, cycling proteins such as the ERGIC-53
homologue p58 can be detected in pleiomorphic structures
adjoining the 
 
cis
 
-side of the Golgi stack and the 
 
cis
 
-cisterna
(Lahtinen et al., 1992; Saraste and Svensson, 1991). To ex-
amine the localization of TAP/p115 in the Golgi, immu-
nogold labeling was performed on frozen sections of rat
pancreas. This tissue was selected because the morphology
of pancreatic acinar cells has been well studied and allows
one to distinguish between the 
 
cis
 
 and 
 
trans
 
-sides of the
Golgi complex (Farquhar, 1981; Farquhar and Palade,
1981). As shown in Fig. 3 
 
A
 
–
 
C 
 
(
 
arrowheads
 
), gold particles
were localized to cisternal and noncisternal elements on
the 
 
cis
 
-side of the Golgi stack. Cisternal labeling was al-
most entirely restricted to the highly fenestrated 
 
cis
 
-most
cisterna, with little labeling of more 
 
medial-
 
cisternae (Fig.
3 
 
A
 
). Noncisternal labeling was found over structures with
a vesicular appearance in close proximity to the 
 
cis
 
-most
cisternae (Fig. 3, 
 
B
 
 and 
 
C
 
). Quantitation of TAP/p115 dis-
tribution close to the Golgi complex in multiple micro-
graphs of distinct pancreatic cells, indicates that 
 
z
 
60% of
gold grains are associated with pleiomorphic structures
and 
 
z
 
40% with the 
 
cis-most cisterna.
Taken together, the data indicate that TAP/p115 associ-
ates with VTCs in the periphery of cells and with the pleio-
morphic structures in the Golgi region and that TAP/p115
cycles between the Golgi and the peripheral VTCs. The
results suggest that TAP/p115 might move with VTCs as
they translocate from cell periphery to the Golgi.
TAP/p115 Binds the cis-Golgi Protein GM130 
Exclusively in the Golgi
TAP/p115 is associated with Golgi and VTC membranes
in vivo (Figs. 1–3) and since TAP/p115 is a soluble pro-
tein, it is likely that its binding to membranes is medi-
ated by interactions with other proteins. To identify
TAP/p115 associated protein(s), anti-TAP/p115 antibod-
ies were used to immunoprecipitate rat liver fractions de-
rived from a PNS (Fig. 4 A, lane PNS), and enriched in
cytosolic (lane cyto), stacked Golgi (lane SG), or ER
(lane ER) components. As shown in Fig. 4 A, approxi-
mately equal amounts of TAP/p115 were recovered from
a Triton X-100–solubilized PNS, cytosolic, and SG frac-
tions, with less TAP/p115 precipitating from the ER frac-
tion. The amount of TAP/p115 in the cytosolic fraction
reflects the peripheral nature of its membrane associa-
tion. TAP/p115 recovered in the ER fraction could be
present on VTCs or the ER since this fraction contained
both, the VTC marker, p58, and the ER marker, calnexin
(data not shown).
A 135-kD protein (p135) coimmunoprecipitated with
TAP/p115 from the Golgi-enriched fraction (Fig. 4 A,
lane SG). p135 did not coimmunoprecipitate when the
anionic detergents SDS and deoxycholate (DOC) were
added to the Golgi fraction (Fig. 4 A, lane SG 1 SDS/
DOC), or when preimmune serum was used (data not
shown), suggesting a specific interaction with TAP/p115.
p135 was purified by large scale coimmunoprecipitation
with TAP/p115 and microsequenced. The sequences of
two tryptic peptides were identical to sequences in the
cis-Golgi protein GM130 (Nakamura et al., 1995). Pep-
tide 1 was identical to the GM130 residues YQELA-
VALDSSYVTNK found at positions 147–162 and peptide
Figure 2. Peripheral struc-
tures containing TAP/p115
are transport intermediates.
NRK cells were treated with
5  mg/ml BFA for 30 min,
fixed, and processed for IF.
TAP/p115 (A) is present in
punctate structures, whereas
mannosidase II (B) is local-
ized to the ER. Cells like in
A and B were treated with 10
mg/ml nocodazole for 90 min.
Cells were then incubated in
medium without BFA but con-
taining  nocodazole (BFA 1
NCO with BFA WO) for 30
min, fixed, and processed for
IF. Mannosidase II (D) redis-
tributed from the ER into punctate structures containing TAP/p115 (C). Cells like in C and D were subjected to nocodazole wash-out
(BFA 1 NCO with BFA WO & NCO WO) for 45 min, fixed, and then processed for IF. TAP/p115 (E) and mannosidase II (F) colocal-
ized in a morphologically normal Golgi complexes. Bar, 10 mm.The Journal of Cell Biology, Volume 143, 1998 324
2 was identical to residues AQVQDNESLSHLNR at po-
sitions 473–487. Our independent finding that TAP/p115
binds GM130 is in agreement with the work from Warren
and colleagues (Nakamura et al., 1997). GM130 is a pe-
ripheral membrane protein localized to multiple cisternae
and pleiomorphic structures on the cis-side of the Golgi
stack (Nakamura et al., 1995).
The finding that the TAP/p115–GM130 complex was
only detected in the SG fraction, despite the fact that
TAP/p115 was present in other fractions suggests that
GM130 distribution might be restricted. To examine this,
distribution of GM130 was compared by immunoblotting
to that of TAP/p115 in cytosolic, SG, and ER fractions. As
shown in Fig. 4 B, GM130 was concentrated in the SG
fraction, with only small amounts detected in the cytosolic
and ER fractions. In contrast, TAP/p115 was detected in
all fractions, in a distribution similar to that seen after im-
munoprecipitation (Fig. 4 A). These results suggest that
Figure 4. TAP/p115 binds GM130 in the Golgi.
(A) TAP/p115 was immunoprecipitated from
PNS (lane PNS), cytosolic (lane cyto), stacked
Golgi (lane SG), and ER (lane ER) fractions sol-
ubilized with Triton X-100 or from the SG frac-
tion solubilized with Triton X-100/SDS/DOC
(lane  SG  1  SDS/DOC). A silver-stained gel is
shown. p135 coimmunoprecipitates with TAP/
p115 only from the SG fraction. (B) Rat liver
fractions were analyzed by immunoblot for the
presence of GM130 and TAP/p115. GM130 was
detected predominantly in the SG fraction
whereas TAP/p115 was also present in cytosolic
and ER fractions. (C) NRK cells were processed
for IF using anti-TAP/p115 and anti-GM130
antibodies. TAP/p115 and GM130 colocalize in
the Golgi region, but GM130 is not detected in
peripheral punctate structures containing TAP/
p115 (arrowheads).
Figure 3. TAP/p115 associates with vesicular tubular structures and cis-Golgi membranes. Immunogold localization of TAP/p115 (ar-
rowheads) in pancreatic acinar cells. Gc, Golgi complex; n, nucleus. Bar, 0.2 mm.Nelson et al. TAP/p115 Localization, Dynamics, and Binding to GM130 325
GM130 is present predominantly in the Golgi whereas
TAP/p115 is expected to have a wider subcellular distribu-
tion. This was supported by double labeling of NRK cells
for GM130 and TAP/p115. As shown in Fig. 4 C, the two
proteins colocalize in the Golgi, but GM130 is not de-
tected in peripheral structures that contain TAP/p115 (ar-
rowheads).
The data suggest that TAP/p115–GM130 complex forms
only in the Golgi. The previously published reports of
GM130 immunogold localization (Nakamura et al., 1997)
and our immunogold localization of TAP/p115 show that
GM130 and TAP/p115 are detected in the cis-Golgi. These
results suggest that the TAP/p115–GM130 complex might
form in the cis-Golgi, but its exact spatial distribution re-
mains to be determined. Significantly, the results indicate
that TAP/p115 association with peripheral VTCs is GM130
independent, and that TAP/p115 binding to VTCs is likely
to be mediated by a protein or proteins other than GM130.
COOH-terminal Acidic Domain of TAP/p115 Interacts 
with GM130
With the goal of testing the functional significance of
TAP/p115 association with GM130, we first mapped their
corresponding binding domains. To identify GM130 bind-
ing sequences within TAP/p115, truncated forms of the
protein were expressed in bacteria and analyzed for their
ability to interact with full-length recombinant GM130.
Any formed complexes were recovered by immunoprecip-
itation with anti-TAP/p115 antibodies. As shown in Fig. 5,
full-length TAP/p115 (lane 2) and NH2 terminally trun-
cated TAP/p115 (lane 5, TAP-N372) bound GM130. Ap-
proximately 4% of the input recombinant GM130 was re-
covered in the TAP/p115 immunoprecipitate. In contrast,
COOH terminally truncated TAP/p115 (Fig. 5, lane 4 ,
TAP-C708) lacking the H3 region and three of the four
coiled coils, failed to bind visible amounts of GM130. A TAP/
p115 construct with a smaller COOH-terminal truncation
and lacking only the acidic domain (lane 3, TAP-C934),
also failed to bind GM130, indicating that the COOH-
terminal region has a critical role in binding GM130.
Using in vitro transcribed/translated GM130 mutants, it
has been shown that the NH2-terminal 74 amino acids of
GM130 are required for binding TAP/p115 (Nakamura et al.,
1997). To confirm this result in our system, we expressed
NH2 terminally truncated GM130 (GM130-N75) in bacte-
ria, and tested its ability to bind cytosolic TAP/p115 or
full-length recombinant TAP/p115. Full-length GM130
bound both cytosolic TAP/p115 (Fig. 5, lane 7) and full-
length recombinant TAP/p115 (lane 6). Approximately
4% of the input recombinant GM130 was recovered in the
TAP/p115 immunoprecipitate. GM130-N75, lacking the
NH2-terminal region did not bind TAP/p115 from either
source (Fig. 5, lanes 8 and 9).
The NH2-terminal region of GM130 contains a stretch
of 26 amino acids with 11 basic residues and only one
acidic residue. The acidic domain of TAP/p115 contains 25
amino acids with 17 acidic residues. This suggests that the
COOH-terminal acidic domain of TAP/p115 directly asso-
ciates with the NH2-terminal basic region of GM130, prob-
ably through charge–charge interactions.
Interaction with GM130 Is Not Required for Golgi 
Localization of TAP/p115
Because TAP/p115 and GM130 interact in the Golgi, bind-
ing to GM130 could have an important role in targeting
TAP/p115 to the Golgi. To address this experimentally,
COS-7 cells were transfected with full-length rat TAP/p115,
COOH terminally truncated forms of TAP/p115 lacking
the GM130-binding domain, or NH2 terminally truncated
forms of TAP/p115 containing the GM130-binding domain,
and their localization in the transfected cells analyzed by im-
munofluorescence. Diagrams of mutants used in this analy-
sis are shown in Fig. 6 A. Two constructs lacking the acidic
domain (TAP-C934 and TAP-C764) and two constructs
containing the acidic domain but lacking an NH2-terminal
region (TAP-N283 and TAP-D62-371) were analyzed.
To ensure that TAP/p115 mutant proteins of the appro-
priate size were produced in transfected cells, expression
of selected constructs was monitored by SDS-PAGE and
immunoblotting. COS-7 cells were transfected and cell ly-
Figure 5. The acidic COOH terminus of TAP/p115 and the basic
NH2 terminus of GM130 are required for binding. Diagram of an-
alyzed constructs. Light gray rectangles, Uso1p homology (H1,
H2, and H3) regions. Dark gray rectangles, coiled-coil domains
(C1–C4). Black rectangle, the acidic domain (A). (Lanes 1–5) Re-
combinant TAP/p115 constructs were incubated with recombi-
nant full-length GM130 (20% of input is loaded in lane 1). Com-
plexes were recovered by immunoprecipitation with anti-TAP/
p115 antibodies. Coomassie blue–stained gel is shown. Full-length
TAP/p115 (lane 2 ) and TAP-N372 (lane 5) bound full-length
GM130, whereas mutants lacking the COOH-terminal acidic do-
main, TAP-C934 (lane 3) and TAP-C708 (lane 4) did not bind
GM130. (Lanes 6–11) Recombinant full-length TAP/p115 or cy-
tosolic TAP/p115 were incubated with recombinant full-length
GM130 (20% of input is loaded in lane 10) or GM130-N75 (20%
of input is loaded in lane 11). Complexes were recovered by
immunoprecipitation with anti-TAP/p115 antibodies. Coomassie
blue–stained gel is shown. Recombinant (lane 6) and cytosolic
(lane 7) TAP/p115 bound GM130, but neither bound GM130-
N75 (lanes 8 and 9). The results indicate that the COOH-terminal
acidic domain of TAP/p115 and the NH2-terminal basic domain
of GM130 are required for binding.The Journal of Cell Biology, Volume 143, 1998 326
sates were prepared 24 h after transfection, subjected to
SDS-PAGE, and then blotted with anti-rat TAP/p115 an-
tibodies. These antibodies were used at low concentration
and recognize the rat and not the simian TAP/p115. As
shown in Fig. 6 B, the endogenous simian TAP/p115 is not
detected on the immunoblot but recombinant rat proteins
of the expected molecular weight are seen (108 kD for
TAP-FL, 86 kD for TAP-C764, and 75 kD for TAP-N283).
The t1/2 of endogenous rat TAP/p115 in NRK cells is z22 h
and the t1/2 of endogenous simian TAP/p115 in COS-7 cells
is z24 h (data not shown). The t1/2 of rat TAP/p115 mu-
tants in transfected COS-7 cells were not significantly dif-
ferent, z22 h for TAP-C764, and z18 h for TAP-D62-371
(data not shown), indicating that the recombinant proteins
have normal turnover rates.
The localization of the wild-type rat TAP/p115 was ex-
plored first, to ensure that the recombinant protein local-
izes correctly in transfected COS-7 cells. In all transfection
IF analyses, anti-TAP/p115 antibodies were used at a low
concentration and detected the recombinant rat TAP/p115
and not the endogenous monkey TAP/p115. As shown in
Fig. 7, A–C, full-length rat TAP/p115 was targeted to the
COS-7 Golgi as evidenced by its colocalization with man-
nosidase II in a juxtanuclear structure with morphology
characteristic of COS-7 Golgi. Recombinant TAP/p115
was also detected in peripheral punctate structures, in a
pattern similar to that seen for endogenous TAP/p115 in
COS-7 cells and likely to represent VTCs (compare Fig. 7
A with Fig. 1 D).
The localization of the COOH terminally truncated mu-
tants was explored next. TAP-C934, lacking the acidic do-
main, was predominantly detected in the Golgi, where it
colocalized with the Golgi marker protein 58K (Bloom
and Brashear, 1989) (Fig. 7, D–F). In addition, TAP-C934
was also detected in peripheral punctate structures, TAP-
C764, lacking the acidic domain and two of the four coiled
coils was also concentrated in the Golgi, where it colocal-
ized with mannosidase II (Fig. 7, G–I). TAP-C764 was also
present in peripheral structures not containing mannosi-
dase II, likely to represent VTCs.
The data show that TAP/p115 mutants lacking the
GM130-binding domain localize efficiently to the Golgi
and can associate with peripheral VTCs. Although the as-
sociation of TAP/p115 with VTCs has been suggested by
previous results to be GM130 independent (refer to Fig. 4
C), the finding that these mutants are efficiently localized
to the Golgi, suggests that TAP/p115 localization to the
Golgi also does not require association with GM130.
An NH2-terminal Region Is Required for Golgi 
Localization of TAP/p115
Localization of two TAP/p115 mutants containing the
GM130 binding domain but lacking portions of the NH2
terminus were analyzed next. As shown in Fig. 8, A–C,
TAP-N283 lacking the NH2-terminal 283 amino acids, was
not concentrated in the Golgi region and did not colocal-
ize well with mannosidase II. Instead, TAP-N283 had a
rather diffuse distribution, resembling the pattern seen for
ER proteins. Indeed, as shown in Fig. 8, D–F, TAP-N283
colocalized with the ER marker calnexin in an extensive
reticular network meandering throughout the cell. Since
TAP-N283 contains the GM130-binding acidic domain, the
distribution of GM130 was analyzed in transfected cells to
determine if GM130 was mislocalized to the ER. As shown
in Fig. 8, G–I, GM130 was localized in a morphologically
normal Golgi complex, in a region of the cell devoid of
TAP-N283.
The NH2-terminal region deleted in TAP-N283 contains
two domains, H1 (amino acids 21–54) and H2 (amino acids
201–252) that are 62% identical to homologous regions in
Uso1p. This high level of conservation suggests an impor-
tant role in TAP/p115 function. To examine the impor-
tance of the H2 domain in TAP/p115 localization, an inter-
nal deletion mutant lacking amino acids 62–371 was
generated (TAP-D62–371). This construct contains the H1
domain but lacks the H2 domain and flanking sequences.
As shown in Fig. 8, J–L, TAP-D62–371 did not appear con-
centrated in the Golgi and was distributed in a reticular
pattern, where it colocalized with calnexin. Since TAP-
D62–371 contains the GM130-binding acidic domain, the
distribution of GM130 was analyzed in transfected cells.
GM130 was detected in morphologically normal Golgi
structures from which TAP-D62–371 seemed restricted
(Fig. 8, M–O).
These results show that the presence of the GM130-
binding domain is not sufficient for Golgi localization of
TAP-N283 and TAP-D62–371. Instead, the NH2-terminal
region and specifically the H2 domain are required for
Golgi localization.
Expression of TAP/p115 Mutants Affects
Golgi Morphology
Expression of mutant forms of cycling proteins involved
in ER to Golgi transport, such as rab1 and arf1, has
been shown to perturb Golgi morphology (Wilson et
Figure 6. TAP/p115 mutants used in transfection
studies. (A) Diagram of analyzed constructs.
Light gray rectangles, Uso1p homology (H1, H2,
and H3) regions. Dark gray rectangles, coiled-coil
domains (C1–C4). Black rectangle, acidic domain
(A). (B) Lysates of COS-7 cells tranfected with
specific TAP/p115 constructs were analyzed by
immunoblotting. Recombinant proteins of the
appropriate molecular weight (z108 kD for
TAP-FL;  z86 kD for TAP-C764, and z75 kD
for TAP-N283) were detected.Nelson et al. TAP/p115 Localization, Dynamics, and Binding to GM130 327
al., 1994; Zhang et al., 1994). To determine the effect of
overexpressing mutant TAP/p115 on Golgi morphology,
localization of mannosidase II was monitored in cells trans-
fected with TAP-C764 (mutant lacking the GM130-bind-
ing domain and localized to the Golgi) or TAP-D62–371
(mutant containing the GM130-binding domain and lo-
calized to the ER).
When TAP-C764–transfected cells were analyzed 36 h
after transfection, mannosidase II was present in mor-
phologically normal Golgi complexes (refer to Fig. 7 H).
However, when cells were examined 63 h after transfec-
tion, cells containing high levels of recombinant TAP-
C764 (Fig. 9 A) showed altered distribution of mannosi-
dase II (Fig. 9 B). Instead of the normal compact Golgi
seen in the untransfected cell in this field, mannosidase
II was found in dispersed structures clustered in the
perinuclear region (Fig. 9 B, arrowhead).
Similar changes in Golgi morphology were observed
with prolonged expression of TAP-D62–371. At early time
points after transfection the Golgi structure appeared
morphologically unperturbed as evidenced by the localiza-
tion of GM130 (refer to Fig. 8 N). However, 63 h after
transfection in cells expressing high levels of recombinant
TAP-D62-371 (Fig. 9 C), mannosidase II was detected in
dispersed punctate structures concentrated in a perinu-
clear region (Fig. 9 D, arrowheads). The mannosidase II–
Figure 7. TAP/p115 mutants
lacking the GM130-binding
domain localize to the Golgi.
Full-length TAP/p115 (A–C),
TAP-C934 (D–F), and TAP-
C764 (G–I) were transiently
expressed in COS-7 cells.
Cells were fixed and pro-
cessed for IF using anti-TAP/
p115 and either anti–man-
nosidase II or anti-58K anti-
bodies. Recombinant pro-
teins were concentrated in
the Golgi region and colocal-
ized with the Golgi markers.
Bars, 10 mm.The Journal of Cell Biology, Volume 143, 1998 328
containing structures in cells expressing the Golgi local-
ized mutant are not readily distinguishable from those in
cells expressing the ER localized mutant (Fig. 9, compare
B with D).
The data suggest that TAP/p115 is required for processes
involved in maintaining Golgi morphology and that the
COOH-terminal (GM130 binding) and the NH2-terminal
(GM130 independent) domains are relevant to this function.
Discussion
Mammalian TAP/p115 and its yeast homologue Uso1p
have been shown to play an essential role in membrane
traffic. TAP/p115 is required in cell-free assays designed to
measure fusion of transcytotic vesicles with the plasma
membrane (Sztul et al., 1993), intra-Golgi transport (Wa-
ters et al., 1992), and regrowth of Golgi cisternae from mi-
totic Golgi fragments (Rabouille et al., 1995, 1998). In
yeast, Uso1p is essential for ER to Golgi transport (Naka-
jima et al., 1991). TAP/p115 has been shown to be re-
quired in the transcytotic assay for docking of transport in-
termediates to acceptor membranes, before ATP hydrolysis
by NSF (Barroso et al., 1995). In agreement with the pro-
posed role of TAP/p115 in vesicle tethering, it has been
shown that TAP/p115 promotes docking of GTP-gS gen-
erated COP I vesicles to Golgi membrane remnants (Sön-
nischen et al., 1998). Similarly, Uso1p appears to perform
a tethering role in ER to Golgi traffic (Barlowe et al.,
1997), acting before the assembly of the ER to Golgi
SNARE complex (Sapperstein et al., 1996) and ATP hy-
drolysis by NSF (Lupashin et al., 1996). To inquire into the
mechanism of TAP/p115 action, we aimed to explore the
compartments in which TAP/p115 is present, characterize
TAP/p115 protein–protein interactions, and define the
functional significance of such interactions.
Localization of TAP/p115
The subcellular localization of TAP/p115 was examined
at the light and electron microscopy levels. In agreement
with previous results (Waters et al., 1992; Nakamura et
al., 1997; Shima et al., 1997), TAP/p115 was found to
colocalize with Golgi marker proteins by immunoflu-
orescence. By EM immunogold labeling, TAP/p115 was
detected in association with pleiomorphic structures adja-
cent to the cis-side of the Golgi stack, and the fenestrated
cis-most cisterna of the stack. TAP/p115 was not detected
to any significant amount in medial- or trans-cisternae.
The localization of TAP/p115 to the cis-Golgi was some-
Figure 8. TAP/p115 mutants with NH2-terminal deletions do not localize to the Golgi. TAP-N283 (A–I) or TAP-D62–371 (J–O) were
transiently expressed in COS-7 cells. Cells were fixed and processed for IF using anti-TAP/p115 and either anti–mannosidase II, anti-
calnexin, or anti-GM130 antibodies. Mutant TAP/p115 did not concentrate with mannosidase II in the Golgi (C), but colocalized with
calnexin in the ER (F and L). Mutants did not cause the redistribution of GM130 from the Golgi to the ER (I and O). Bar, 10 mm.Nelson et al. TAP/p115 Localization, Dynamics, and Binding to GM130 329
what surprising considering the previously described role
for TAP/p115 in cis- to medial–intra-Golgi transport (Wa-
ters et al., 1992). Proteins that localize exclusively to the
cis- part of the Golgi stack (for example: rab1 [Saraste et
al., 1995], syntaxin 5 [Banfield et al., 1994] and ERGIC-53
[Itin et al., 1995]) have been predominantly those in-
volved in ER to Golgi traffic rather than in subsequent
steps of transport. This finding is consistent with the pos-
sibility that TAP/p115 might function in ER to Golgi
traffic.
Cycling of TAP/p115
In addition to the Golgi localization, TAP/p115 was also
detected in peripheral punctate structures, likely to repre-
sent VTCs (Bannykh and Balch, 1997). Morphologically,
VTCs are composed of clusters of tubular and vesicular
profiles that form throughout the cell, close to ER exit
sites (Bannykh and Balch, 1997). VTCs translocate by a
microtubule dependent mechanism towards the Golgi and
then fuse (Presley et al., 1997). Whether VTCs fuse with
preexisting structures or with each other is currently unre-
solved (for review see Lippincott-Schwartz et al., 1998).
VTCs are transient structures and proteins detected
therein have been shown to cycle between the Golgi and
earlier compartments of the secretory pathway. TAP/p115
localization to VTCs suggested that TAP/p115 might also
cycle. One of the hallmarks of cycling proteins is their re-
distribution in cells incubated at reduced temperatures. In-
cubation at 158C inhibits the translocation of VTCs from
the periphery to the Golgi region without significantly af-
fecting the retrograde cycling of the proteins, resulting in
the net redistribution of these proteins from the Golgi re-
gion to peripheral structures. In addition to ERGIC-53,
proteins known to exhibit this behavior include the cycling
transmembrane proteins the KDEL receptor (Tang et al.,
1993), mammalian Sec13 (Tang et al., 1997), p23 (Rojo et al.,
1997), and rbet1 (Zhang et al., 1997); and the peripherally
associated proteins, b-COP (Griffiths et al., 1995), and
rab1 (Saraste et al., 1995). Consistent with the behavior of
other cycling proteins, incubation of cells at 158C caused
redistribution of TAP/p115 from the Golgi to peripheral
punctate structures containing ERGIC-53. The redistribu-
tion of TAP/p115 indicates that it cycles at least through
VTCs and the Golgi. Many cycling proteins have been
shown to transit through the ER (for review see Pelham,
1991), but whether TAP/p115 also cycles through the ER
remains to be determined.
TAP/p115 localization to peripheral VTCs and its exten-
sive cycling between the Golgi and earlier compartments
of the secretory pathway suggests that TAP/p115 might as-
sociate with peripheral VTCs and be transported with
them as they move from cell periphery to the Golgi region.
Such a delivery mechanism for TAP/p115 would require
the specific association of TAP/p115 with peripheral
VTCs, but the subsequent transport to the Golgi would oc-
cur by default. Therefore, Golgi localization of TAP/p115
would not require a specific Golgi receptor.
Interaction between TAP/p115 and GM130
Previous reports showed that TAP/p115 interact with the
tightly associated Golgi protein GM130 and mapped the
TAP/p115 interacting domain within the GM130 to the ba-
sic NH2-terminal region (Nakamura et al., 1997). We de-
fined the GM130-binding domain within TAP/p115 using
an in vitro binding assay, and showed that the highly con-
served COOH-terminal acidic domain of TAP/p115 is re-
Figure 9. Expression of
TAP/p115 mutants leads to
loss of characteristic Golgi
morphology. TAP-C764 (A
and  B) and TAP-D62–371 (C
and D) were transiently ex-
pressed in COS-7 cells, and
63 h after transfection cells
were fixed and processed for
IF using anti–mannosidase
II and anti-TAP/p115 anti-
bodies. In cells expressing
high levels of mutant TAP/
p115 (A and C), mannosidase
II is found in punctate struc-
tures clustered in the perinu-
clear region (arrowheads in B
and D). Bar, 10 mm.The Journal of Cell Biology, Volume 143, 1998 330
quired to bind the NH2-terminal basic region of GM130.
The results suggest a possible linear tail to head binding of
TAP/p115 and GM130. TAP/p115 is a homodimer with
two globular heads (z9 nm) composed of the NH2-termi-
nal regions of each monomer and a tail (z45 nm) formed
by the dimerization and close parallel apposition of four
independent coiled-coil regions from each TAP/p115
monomer (Sapperstein et al., 1995). The acidic domain is
found at the COOH terminus following the last coiled-coil
region. GM130 is predicted (based on amino acid sequence)
to exist as a long (z100 nm) rod-like homodimer com-
posed of parallel apposition of seven distinct coiled-coil
regions in each GM130 monomer. Binding of the COOH
terminus of TAP/p115 to the NH2-terminus of GM130
would result in a z150-nm-long structure, an arrangement
that might be functionally important.
What is the relevance of TAP/p115–GM130 complex
formation? Based on the finding that microinjection of
peptide corresponding to the TAP/p115 binding domain of
GM130 blocked TAP/p115 association with Golgi mem-
branes in vivo, it was proposed that GM130 acts as a Golgi
receptor for TAP/p115 (Nakamura et al., 1997). To test
this hypothesis, we examined the localization of TAP/p115
mutants lacking the GM130-binding domain in transfected
cells. Two mutants (TAP-C934 and TAP-C764), were
shown to efficiently localize to the Golgi and to associate
with peripheral VTCs. These results indicate that targeting
of TAP/p115 to the Golgi and the VTCs does not require
binding to GM130. The data are consistant with the hy-
pothesis that TAP/p115 might be delivered to the Golgi by
VTCs and that the ability to associate with VTCs might be
sufficient for Golgi localization. However, real time obser-
vation of TAP/p115 movement on VTCs will be required
to unequivocally confirm this hypothesis.
Interestingly, the presence of the GM130-binding do-
main is not sufficient to target TAP/p115 to the Golgi.
Two mutants (TAP-N283 and TAP-D62-371) with dele-
tions in the NH2-terminal region but containing the
GM130-binding domain were not localized to the Golgi.
Instead, they were restricted to the ER, where they colo-
calized with calnexin. It is possible that these mutants
could not associate with peripheral VTCs and thus could
not be transported to the Golgi.
Earlier studies showed that TAP/p115 is required for cis
to medial step of intra-Golgi transport in an in vitro assay
(Waters et al., 1992), but the exact molecular interactions
were not defined. Recently, Sönnischen et al. (1998) have
shown that TAP/p115 binds to giantin on COP I vesicles
derived from GTP-gS–treated Golgi membranes and to
GM130 present on the remaining membranes, and thereby
might bridge the COP I vesicles and the Golgi membranes.
However, since the vesicles generated after GTP-gS treat-
ment are not functional transport intermediates (Weidman
et al., 1993) and their exact origin and destination are un-
certain, the significance of the proposed GM130–TAP/
p115–giantin interaction remains unclear. It will be impor-
tant to determine what Golgi process is dependent on the
GM130–TAP/p115–giantin interaction and what is the na-
ture and dynamics of complex formation between these
proteins.
Although the exact site of TAP/p115–GM130 complex
formation within the Golgi is unknown, our results suggest
the possibility that the interaction might occur between
TAP/p115 on the surface of incoming VTCs and GM130
on the acceptor cis-Golgi membrane. If TAP/p115 is deliv-
ered to the Golgi on VTCs, the complex might form as
part of a docking interaction before membrane fusion. The
elongated structure of TAP/p115 and GM130, and the pos-
sible tail to head association of these molecules during
binding seem well suited for a tethering interaction. Such a
model is consistent with all available data but remains to
be confirmed.
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